CD44 and cancer: In prostate cells, SND1 recruits splicing factor SAM68 and other spliceosomal components on CD44 pre-mRNA, promotes the inclusion of CD44 variable exons, which correlates with increased proliferation, motility, and invasiveness of cancer cells [27].